GlassScriptPhysician profile
Amy Mclain
NPI 1487197034
$1,956.27
in general payments reported to CMS, 2019-2025
18 companies · $467 in 2025
The $467 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $388 · 2023: $473 · 2024: $629 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,568.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $406.68 | 2022-2025 | Evenity, Prolia, Repatha |
| Pfizer INC. | $297.43 | 2022-2025 | |
| Novo Nordisk INC | $253.45 | 2022-2025 | Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $233.61 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $137.26 | 2023-2025 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $105.11 | 2022-2025 | Jardiance |
| Abbvie INC. | $98.15 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $72.25 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $61.07 | 2022-2023 | Xarelto |
| Sanofi-Aventis U.S. LLC | $55.82 | 2022-2023 | |
| Abbott Laboratories | $54.77 | 2024 | Freestyle Libre 3 |
| Phadia US INC. | $35.65 | 2023 | Immunocap |
| Merck Sharp & Dohme LLC | $33.13 | 2022-2024 | Gardasil, Gardasil 9, Vaxelis |
| Biohaven Pharmaceutical Holding Company LTD. | $32.66 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.17 | 2022-2023 | Xifaxan |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $19.17 | 2022 | |
| Tactile Systems Technology INC | $16.46 | 2022 | |
| Electromed, INC. | $12.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Mclain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.